174 related articles for article (PubMed ID: 27764800)
1. GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.
Cox DG; Curtit E; Romieu G; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Deleuze JF; Pauporté I; Thomas G; Pivot X
Oncotarget; 2016 Nov; 7(47):77358-77364. PubMed ID: 27764800
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
3. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
[TBL] [Abstract][Full Text] [Related]
4. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
[TBL] [Abstract][Full Text] [Related]
5. Allelic imbalance at the HER2/TOP2A locus in breast cancer.
Huijsmans CJ; van den Brule AJ; Rigter H; Poodt J; van der Linden JC; Savelkoul PH; Hilbink M; Hermans MH
Diagn Pathol; 2015 May; 10():56. PubMed ID: 26022247
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
[TBL] [Abstract][Full Text] [Related]
7. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
8. [Association of FGFR2 gene polymorphism with estrogen receptor positive breast cancer detected by fluorescent quantitative PCR].
Ren L; Zhang B; Cao XC; Chen Y; Ge J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Aug; 27(4):445-8. PubMed ID: 20677155
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.
Liang J; Chen P; Hu Z; Zhou X; Chen L; Li M; Wang Y; Tang J; Wang H; Shen H
Carcinogenesis; 2008 Dec; 29(12):2341-6. PubMed ID: 18845558
[TBL] [Abstract][Full Text] [Related]
10. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
11. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.
Teraoka SN; Bernstein JL; Reiner AS; Haile RW; Bernstein L; Lynch CF; Malone KE; Stovall M; Capanu M; Liang X; Smith SA; Mychaleckyj J; Hou X; Mellemkjaer L; Boice JD; Siniard A; Duggan D; Thomas DC; ; Concannon P
Breast Cancer Res; 2011; 13(6):R114. PubMed ID: 22087758
[TBL] [Abstract][Full Text] [Related]
13. Gene-based analysis of the fibroblast growth factor receptor signaling pathway in relation to breast cancer in African American women: the AMBER consortium.
Ruiz-Narváez EA; Haddad SA; Lunetta KL; Yao S; Bensen JT; Sucheston-Campbell LE; Hong CC; Haiman CA; Olshan AF; Ambrosone CB; Palmer JR
Breast Cancer Res Treat; 2016 Jan; 155(2):355-63. PubMed ID: 26743380
[TBL] [Abstract][Full Text] [Related]
14. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women.
Liang H; Yang X; Chen L; Li H; Zhu A; Sun M; Wang H; Li M
Biomed Res Int; 2015; 2015():626948. PubMed ID: 26421298
[TBL] [Abstract][Full Text] [Related]
16. SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.
Chan HJ; Li H; Liu Z; Yuan YC; Mortimer J; Chen S
Oncotarget; 2015 Sep; 6(28):25815-27. PubMed ID: 26158350
[TBL] [Abstract][Full Text] [Related]
17. Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci.
Reeves GK; Travis RC; Green J; Bull D; Tipper S; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
JAMA; 2010 Jul; 304(4):426-34. PubMed ID: 20664043
[TBL] [Abstract][Full Text] [Related]
18. Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population.
He Y; Liu H; Chen Q; Sun X; Liu C; Shao Y
Tumour Biol; 2016 Jul; 37(7):9739-44. PubMed ID: 26803517
[TBL] [Abstract][Full Text] [Related]
19. Crosstalk between the FGFR2 and TP53 genes in breast cancer: data from an association study and epistatic interaction analysis.
Cherdyntseva NV; Denisov EV; Litviakov NV; Maksimov VN; Malinovskaya EA; Babyshkina NN; Slonimskaya EM; Voevoda MI; Choinzonov EL
DNA Cell Biol; 2012 Mar; 31(3):306-16. PubMed ID: 21838531
[TBL] [Abstract][Full Text] [Related]
20. FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness.
Campbell TM; Castro MAA; de Santiago I; Fletcher MNC; Halim S; Prathalingam R; Ponder BAJ; Meyer KB
Carcinogenesis; 2016 Aug; 37(8):741-750. PubMed ID: 27236187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
